Nicole Eustace
Family Medicine · Davenport, IANPI 1346505278
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 27.7% of the total. 2025 is the largest year on record at $803, more than ten times the $29 reported in 2020. Among family medicine clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$707
- Otsuka America Pharmaceutical, Inc.$512
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$258
- Pfizer$247
- AstraZeneca$98
- Astellas Pharma US Inc$86
- plus $645 from 20 others
What the payments were for
- Food & beverage$2,552100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $707 |
| Otsuka America Pharmaceutical, Inc. | 22 | $512 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $258 |
| Pfizer | 16 | $247 |
| AstraZeneca | 5 | $98 |
| Astellas Pharma US Inc | 4 | $86 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Novo Nordisk | 4 | $65 |
| Lundbeck LLC | 4 | $64 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $48 |
| Lilly USA, LLC | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Corium, LLC | 2 | $37 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Ironshore Pharmaceuticals Inc. | 2 | $32 |
| Amgen | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Vertex | 1 | $23 |
| Impel Pharmaceuticals Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Exact Sciences | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Tris Pharma Inc | 1 | $13 |
| Organon | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,552 in reported general payments places this provider in the 90th percentile of 1,357 family medicine providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 32 | $34,063 |
| EliquisApixaban | 13 | $14,451 |
| Bydureon BciseExenatide Microspheres | 14 | $11,394 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 25 | $6,119 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,051 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $3,527 |
| Esomeprazole Magnesium | 12 | $2,464 |
| Gabapentin | 110 | $2,160 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 82 | $2,087 |
| Metoprolol Succinate | 123 | $1,597 |
| Atorvastatin Calcium | 233 | $1,377 |
| Omeprazole | 106 | $1,296 |
| Potassium Chloride | 31 | $1,243 |
| Ventolin HfaAlbuterol Sulfate | 13 | $1,224 |
| Duloxetine Hcl | 36 | $1,179 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $46 | $34,06332 claims |
| PfizerEliquis | $247 | $14,45113 claims |
| AbbVieSynthroid | $707 | $78517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,357 family medicine providers in Iowa.
Other family medicine in Davenport
- Linda JagerDavenport$7K
- Kirk PetersonHuxley$576K
- Nicholas GoetschWaterloo$525K
- Stephen HarrisonClinton$249K
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
- Leslie George PaulsenMuscatine$136K
- Dylan LoweDes Moines$105K
- Michael AbouassalyWest Burlington$88K
- Kevin DeregnierWinterset$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.